Black Box Warning: More information
REMS: Ultomiris REMS
Search results for:
ravulizumab
ravulizumab
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-formulary |
Interchange |
| Ultomiris |
SOLUTION FOR INFUSION |
300 mg/3 ml: 1100 mg/11 ml |
|
|
|
|
Last updated: Sep. 4, 2026
Use of Ravulizumab is restricted to patients who meet the REMS program requirements and must be prescribed by a REMS certified prescriber.
An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:
Ultomiris: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761108s023lbl.pdf#page=41